ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ORIC Pharmaceuticals Appoints Steven L. Hoerter to its Board of Directors
August 17, 2021ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the appointment of 25-year industry veteran Steven L. Hoerter to its Board of Directors. -
Oric closes funding to develop glucocorticoid antagonist ORIC-101
August 12, 2019Oric Pharmaceuticals has closed a Series D financing to support the continued development of a clinical-stage, selective and potent glucocorticoid receptor antagonist, ORIC-101. -
ORIC Pharmaceuticals Appoints Chief Scientific Officer
July 10, 2019Lori Friedman, PhD to lead ORIC's research and preclinical development efforts.
Pharma Sources Insight January 2025
